Skip to content

Stanford engineer Ellen Kuhl is using computer modeling to provide insight into the progress of neurodegenerative diseases like Alzheimer's.

Stanford engineer Ellen Kuhl is using computer modeling to provide insight into the progress of neurodegenerative diseases like Alzheimer's.

Published on

Stanford innovators have created ways to fit MRI scanning equipment to kids instead of the other way around. Adult patients can benefit, too.

Stanford innovators have created ways to fit MRI scanning equipment to kids instead of the other way around. Adult patients can benefit, too.

Published on

A new imaging technology that harnesses fluorescence allows scientists to detect tuberculosis in an hour and to measure drug efficacy.

A new imaging technology that harnesses fluorescence allows scientists to detect tuberculosis in an hour and to measure drug efficacy.

A recent lecture by clinician-researcher Daniel Bernstein highlighted an imaging technique for assessing the diverse ways mitochondria behave within heart cells.

A recent lecture by clinician-researcher Daniel Bernstein highlighted an imaging technique for assessing the diverse ways mitochondria behave within heart cells.

Researchers have used an ultrafast, intense X-ray laser to observe how Mycobacterium tuberculosis bacteria attack antibiotics, making the drugs ineffective.

Researchers have used an ultrafast, intense X-ray laser to observe how Mycobacterium tuberculosis bacteria attack antibiotics, making the drugs ineffective.

Scientists at Stanford have created a new PET scan-compatible tracing agent that tracks immune cells poised to attack cancer, offering a new way to predict the success of certain therapies.

Scientists at Stanford have created a new PET scan-compatible tracing agent that tracks immune cells poised to attack cancer, offering a new way to predict the success of certain therapies.

A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.

A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.

Published on

Stanford's Mary Leonard has devoted her research career to understanding how chronic diseases weaken children's bones, and what we can do about it.

Stanford's Mary Leonard has devoted her research career to understanding how chronic diseases weaken children's bones, and what we can do about it.

Published on